SULF2 inhibition sensitizes TNBC to paclitaxel

Posted in News

Manouchehri JM, Datta J, Marcho LM, Stover D, Ganju RK, Ramaswamy B, Carson WE, Mittra A, Zhang X, Schnell PM, Yue Y, Rubinstein MP, Cherian MA. Sulfatase 2 inhibition sensitizes triple-negative breast cancer cells to paclitaxel through augmentation of extracellular ATP. Cancer Biol Ther. 2025 Dec;26(1):2483989. doi: 10.1080/15384047.2025.2483989. Epub 2025 Mar 26. PMID: 40140347